Larvol Delta - Black-Diamond-Therapeutics-AnnouncesPlans-for-a-Phase-2-Trial-of-Silevertinib-in-GBM

silevertinib (BDTX-1535) - Black Diamond Therap

https://www.globenewswire.com/news-release/2025/12/03/3198744/0/en/black-diamond-therapeutics-announces-preliminary-phase-2-data-for-silevertinib-in-1l-nsclc-and-plans-for-a-phase-2-trial-of-silevertinib-in-gbm.html

Dec 3, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next